Rise in the geriatric population, surge in healthcare expenditure, and rise in prevalence of hypertension across the globe drive the growth of the global antihypertensive drugs market. However, patent expirations of blockbuster drugs hamper the market growth. On the contrary, high growth potential in developing countries is expected to create lucrative opportunities in the near future.
According to the report published by Allied Market Research, the global antihypertensive drugs market accounted for $22,557 million in 2018, and is expected to reach $28,797 million by 2026, registering a CAGR of 3.1% from 2019 to 2026. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/436
Onkar Sumant, a Manager, Healthcare at Allied Market Research, stated, The demand for antihypertensive drugs is on a rise, owing to surge in incidence of hypertension. Furthermore, rise in awareness related to treatment of hypertension across the globe is another factor that fuels the growth of the market.
Key Findings of the Study:
- Calcium channel blockers occupied one-fourths share of the global antihypertensive drugs market in 2018.
- The ACE inhibitors segment is anticipated to grow with the highest CAGR throughout the forecast period.
- The vasodilators accounted for more than one-fifths share of the market in 2018.
- Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
North America dominated the market
The global antihypertensive drugs market across North America held the largest share in 2018, accounting for more than one-third of the market, owing to the availability of the antihypertensive drugs and rise in prevalence of hypertension due to surge in geriatric population in the region. However, the market across the Asia-Pacific region is anticipated to portray the fastest CAGR of 4.2% during the forecast period, owing to surge in awareness related to use of antihypertensive drugs and the presence of active key players in the region.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/436
Major market players
- Boehringer Ingelheim GmbH
- Johnson and Johnson
- Merck KGaA
- Pfizer, Inc.
- Bayer AG
- AstraZeneca plc
- Takeda Pharmaceutical Co., Ltd.
- Sanofi S.A.
- Daiichi Sankyo Company
- Novartis International AG
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains.
Contact us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285 |UK: +44-845-528-1300 | Hong Kong: +852-301-84916 | India (Pune): +91-20-66346060 | Fax: +1-855-550-5975 Email” help@alliedmarketresearch.com
Follow us on LinkedIn, Facebook, Twitter, Pinterest, YouTube & Instagram